Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 Diabetes
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine whether a initial combination of linagliptin and
metformin compared to linagliptin alone for 24 weeks is effective in newly diagnosed,
treatment-naïve patients with Type 2 Diabetes.